FOCL
ARAY

Joshua Levine

Known title: DirectorCIK: 0001159917

Joshua Levine's purchase track record

Joshua Levine has no open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.

PurchaseStockAmount3 months6 months
8/14/2026FOCL$48Kpendingpending
5/11/2026FOCL$42K+45.8%pending

Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 27, 2026

FOCL ADRs See Minor Daily Fluctuations in US Trading. FOCL, an ADR of EDAP TMS S.A., is part of the European ADR group that moved slightly higher on Friday, lower on Thursday, and declined on Tuesday. The ADRs’ daily swings reflect broader market sentiment rather than company‑specific news. The stock remains near its 52‑week range and is trading above its 200‑day SMA.

this person other insiders at FOCL

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 30, 2026

Accuray (ARAY) noted among health‑care stocks moving in recent sessions. Accuray appeared in several recent lists of health‑care stocks showing price movement in pre‑market, after‑market and intraday sessions. The activity comes as the stock trades near its $0.25 support level with an RSI around 58, suggesting modest momentum. Analysts have an average target of $0.35, above the current price.

this person other insiders at ARAY

Transaction History

FOCL▲ Buy$48K
FOCL▲ Buy$42K
ARAY▼ Sell$62K
ARAY▲ Buy$0
ARAY▲ Buy$0

We use analytics to understand how market-wall is used. No personal data is sold.